Quetiapine Fumarate
Product Images NDC 50436-6338

5 FDA label images from Unit Dose Services · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 50436-6338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504366338)

Label Image (Lbl504366338)
QUETIAPINE FUMARATE 100 MG tablet label showing NDC 50436-6338-0. Manufactured by Accord, package distributed by Unit Dose Services, LLC, Flint, MI. Label includes storage instructions and warnings to keep out of reach of children.*
FDA Label Image

Label Image (Lbl504366339)

Label Image (Lbl504366339)
QUETIAPINE FUMARATE 25 MG tablet unit dose packaging label showing 30 tablets. Manufactured by Accord, distributed by Unit Dose Services, LLC, Highland Park, IL. Label includes NDC 50436-6339-0 and storage instructions to keep at controlled room temperature.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)
A line graph depicting the proportion of patients with relapse (%) over time (weeks) up to 100 weeks. Two treatment groups are compared: QTP plus Li/VAL (dashed line) and PDL plus Li/VAL (solid line). The graph shows the relapse percentage increasing over time for both groups, with PDL plus Li/VAL showing a higher relapse proportion than QTP plus Li/VAL.*
FDA Label Image

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)
A line graph depicting the proportion of patients with relapse (%) over time in weeks. Two groups are compared: one treated with Quetiapine Fumarate plus Li/Val (dashed line) and the other with placebo plus Li/Val (solid line). The graph shows relapse proportions increasing over time for both groups, with the placebo group exhibiting a higher relapse rate throughout the observation period.*
FDA Label Image

Chemstructure (Quetiapine Str)

Chemstructure (Quetiapine Str)
Chemical structure diagram of quetiapine fumarate showing the molecular arrangement of the active ingredient's components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.